Vladimir Makarov
National Research University Higher School of Economics
H-index: 52
Europe-Russia
Top articles of Vladimir Makarov
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Topological heterogeneity of genomic and immunologic effects from combination immunotherapy treatment in the neoadjuvant setting for renal cell carcinoma (RCC). | Tyler Alban Salendra Singh Paul G Pavicic Patricia A Rayman Prerana Parthasarathy Bangalore | 2024/2/1 | |
Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting. | Nikhil Pramod Vladimir Makarov Scott Dawsey Paul G Pavicic Ubenthira Patgunarajah | 2024/2/1 | |
Novel genetic subtypes of urothelial carcinoma with differential outcomes on immune checkpoint blockade | Journal of Clinical Oncology | Michal Sarfaty Mahdi Golkaram Samuel A Funt Hikmat Al-Ahmadie Shannon Kaplan | 2023/6/10 |
AI-based pathologic biomarker for pathologic downstaging in patients with muscle-invasive bladder cancer undergoing cystectomy after neoadjuvant nivolumab, gemcitabine, and … | Viswesh Krishna Guru P Sonpavde Sumati Gupta Benjamin L Maughan Neeraj Agarwal | 2023/6/1 | |
Fibroblast growth factor receptor 3 (FGFR3) alterations in PROOF 302: A phase III trial of infigratinib (BGJ398) as adjuvant therapy in patients (pts) with invasive … | Petros Grivas Siamak Daneshmand Vladimir Makarov Joaquim Bellmunt Srikala S Sridhar | 2023/6/1 | |
KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer | Cancer research | Hong Qiu Vladimir Makarov Jennifer K Bolzenius Angela Halstead Yvonne Parker | 2023/3/15 |
Abstract P1-04-04: A multiomic approach to the identification of immune signatures of anti-PD1/PDL1 therapy responders in metastatic triple negative breast cancer: new … | Cancer Research | Avia D Wilkerson Patricia A Rayman Paul G Pavicic Jr Hana Husic Vladimir Makarov | 2023/3/1 |
Genomic analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy. | Shilpa Gupta Vladimir Makarov Guru P Sonpavde Ewan Gibb Sumati Gupta | 2023/2/20 | |
The use of information technology in the design of chippers for the production of technological chips | E3S Web of Conferences | Vladimir Sivakov Sergey Gryadunov Anatoliy Buglaev Maria Lushpaeva Oksana Timokhova | 2023 |
Vladimir Sivakov, Sergey Gryadunov, Anatoliy Buglaev, Maria Lushpaeva, Oksana Timokhova, Vladimir Makarov. The use of information technology in the design of chippers for the … | Vladimir Sivakov Sergey Gryadunov Anatoliy Buglaev Maria Lushpaeva Oksana Timokhova | 2023 | |
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression | OncoImmunology | Paul G Pavicic Jr Patricia A Rayman Shadi Swaidani Amit Rupani Vladimir Makarov | 2023/12/31 |
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial | Nature medicine | Joris L Vos Bharat Burman Swati Jain Conall WR Fitzgerald Eric J Sherman | 2023/12 |
Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities | Cancer Research Communications | Ian Ganly Fengshen Kuo Vladimir Makarov Yiyu Dong Ronald Ghossein | 2023/7/31 |
Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts). | Amanda Nizam Alice Tzeng Wei Wei Patricia A Rayman Paul G Pavicic | 2022/2/20 | |
Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity | Molecular cancer therapeutics | Yiyu Dong Yongxing Gong Fengshen Kuo Vladimir Makarov Ed Reznik | 2022/2/1 |
The Vladimir State University special issue based on the results of the conference MNNSI-2021 | Journal of Physics: Conference Series | Sergey Arakelian Stella Kutrovskaya Alexey Kucherik Anton Osipov Andrey Evlyukhin | 2022 |
Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma | Journal for immunotherapy of cancer | Candice Church Thomas Pulliam Natalie Longino Song Y Park Kimberly S Smythe | 2022 |
Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy | Molecular Cancer Research | Mark Lee Brian R Untch Bin Xu Ronald Ghossein Catherine Han | 2022/1/1 |
Abstract A019: Epigenetic regulation by H3K9 methylation enables resistance to anti-androgen therapy in prostate cancer | Cancer Research | Ritika Tiwari Mehdi Baratchian Michael Berk Jianneng Li Amy Guerinot | 2022/12/1 |
A targetable myeloid inflammatory state governs disease recurrence in clear-cell renal cell carcinoma | Cancer discovery | Phillip M Rappold Lynda Vuong Josef Leibold Nicholas H Chakiryan Michael Curry | 2022/10/5 |
